Evaluation of Subjects Experiencing Allergic Reactions to Non-Steroidal Anti-Inflammatory Drugs: Clinical Characteristics and Drugs Involved

被引:6
|
作者
Perez-Sanchez, Natalia [1 ,2 ]
Dona, Inmaculada [1 ]
Bogas, Gador [1 ]
Salas, Maria [1 ]
Testera, Almudena [1 ]
Cornejo-Garcia, Jose A. [3 ]
Torres, Maria J. [1 ,2 ,3 ,4 ]
机构
[1] Malaga Reg Univ Hosp, Allergy Unit, Malaga, Spain
[2] Univ Malaga, Dept Med, Malaga, Spain
[3] ARADyAL, Allergy Res Grp, Inst Invest Biomed Malaga IBIMA, Malaga, Spain
[4] Andalusian Ctr Nanomed & Biotechnol BIONAND, Nanostruct Diagnosing & Treatment Allerg Dis Lab, Malaga, Spain
来源
FRONTIERS IN PHARMACOLOGY | 2020年 / 11卷
关键词
drug allergy; non-steroidal anti-inflammatory drugs; urticarial; anaphylaxis; clinical immunology; HYPERSENSITIVITY REACTIONS; INDUCED ANAPHYLAXIS; BASOPHIL ACTIVATION; RESPONSE PATTERNS; IGE ANTIBODIES; DIAGNOSIS; IMMEDIATE; HISTORY; NSAIDS; CLASSIFICATION;
D O I
10.3389/fphar.2020.00503
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Non-steroidal anti-inflammatory drugs (NSAIDs), the most commonly prescribed and consumed medicines worldwide, are the main triggers of drug hypersensitivity reactions (DHRs). The underlying mechanisms of NSAID-DHRs may be related to COX-1 inhibition (cross-hypersensitivity reactions, CRs) or to immunological recognition (selective reactions, SRs), being the latter remarkably less studied. SRs include those usually appearing within the first hour after drug intake (single-NSAID-induced urticaria/angioedema or anaphylaxis, SNIUAA), and those usually occurring more than 24 h after (single-NSAID-induced delayed reactions, SNIDR). We have evaluated the largest series of patients with SRs, analyzing the number of episodes and drugs involved, the latency for reaction onset, the clinical entities, among other variables, as well as the value of available diagnostic methods. Globally, pyrazolones and arylpropionics were the most frequent culprits (39.3% and 37.3%, respectively). Pyrazolones were the most frequent triggers in SNIUAA and arylpropionics in SNIDR. Urticaria was the most common clinical entity in SNIUAA (42.4%) followed by anaphylaxis (33.3%); whereas SNIDR induced mostly fixed drug eruption (41.1%) and maculopapular exanthema (32.6%). The percentage of patients diagnosed by clinical history was higher in SNIUAA compared with SNIDR (62.7% versus 35.3%, p = 0.00015), whereas the percentage of those diagnosed by skin tests was higher in SNIDR than in SNIUAA (47.1% versus 22.8%, p = 0.00015). Drug provocation test with the culprit was performed in 67 SNIUAA (14.5%) and in 9 SNIDR (17.6%) patients. Our results may be of interest not only for allergologists but also for other clinicians dealing with these drugs, and can be useful for the correct identification of subjects experiencing DHRs to NSAIDs, and for avoiding mislabeling. Moreover, as NSAIDs are highly consumed worldwide, our results may be of interest for evaluating other populations exposed to these drugs.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Characterization of subjects experiencing blended hypersensitivity reactions to non-steroidal anti-inflammatory drugs
    Barrionuevo, E.
    Dona, I
    Salas, M.
    Bogas, G.
    Guerrero, M. A.
    Sanchez, M., I
    Cornejo-Garcia, J. A.
    Torres, M. J.
    [J]. ALLERGY, 2017, 72 : 265 - 266
  • [2] Characteristics of subjects experiencing hypersensitivity to non-steroidal anti-inflammatory drugs: patterns of response
    Dona, I.
    Blanca-Lopez, N.
    Cornejo-Garcia, J. A.
    Torres, M. J.
    Laguna, J. J.
    Fernandez, J.
    Rosado, A.
    Rondon, C.
    Campo, P.
    Agundez, J. A.
    Blanca, M.
    Canto, G.
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 2011, 41 (01): : 86 - 95
  • [3] Pseudo Allergic Reactions to paracetamol and non-steroidal anti-inflammatory drugs
    Affes, A.
    Hammami, S.
    Ghozzi, H.
    Ksouda, K.
    Ayedi, L.
    Ben Mahmoud, L.
    Hakim, A.
    Sahnoun, Z.
    Zeghal, K.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2009, 23 : 42 - 42
  • [4] Cutaneous Reactions to Non-steroidal Anti-inflammatory Drugs
    Kasemsarn, Pranee
    Kulthanan, Kanokvalai
    Tuchinda, Papapit
    Dhana, Naruemon
    Jongjarearnprasert, Kowit
    [J]. JOURNAL OF DRUGS IN DERMATOLOGY, 2011, 10 (10) : 1160 - 1167
  • [5] Allergic and pseudoallergic reactions to antalgics, antipyretics and non-steroidal anti-inflammatory drugs
    Ponvert, C.
    Scheinmann, P.
    [J]. ARCHIVES DE PEDIATRIE, 2007, 14 (05): : 507 - 512
  • [6] Hypersensitivity Reactions to Non-Steroidal Anti-Inflammatory Drugs
    Dona, Inmaculada
    Salas, Maria
    Perkins, James R.
    Barrionuevo, Esther
    Gaeta, Francesco
    Cornejo-Garcia, Jose A.
    Campo, Paloma
    Jose Torres, Maria
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (45) : 6784 - 6802
  • [7] Hypersensitivity Reactions to Non-Steroidal Anti-Inflammatory Drugs
    Antonio Cornejo-Garcia, Jose
    Blanca-Lopez, Natalia
    Dona, Inmaculada
    Andreu, Inmaculada
    Agundez, Jose A. G.
    Carballo, Miguel
    Blanca, Miguel
    Gabriela Canto, Maria
    [J]. CURRENT DRUG METABOLISM, 2009, 10 (09) : 971 - 980
  • [8] Allergic and pseudoallergic reactions to antalgics, antipyretics and non-steroidal anti-inflammatory drugs
    Ponvert, C.
    Scheinmann, P.
    [J]. REVUE FRANCAISE D ALLERGOLOGIE ET D IMMUNOLOGIE CLINIQUE, 2006, 46 (06): : 576 - 583
  • [9] SKIN REACTIONS TO NON-STEROIDAL ANTI-INFLAMMATORY DRUGS
    ROUJEAU, JC
    GUILLAUME, JC
    REVUZ, J
    TOURAINE, R
    [J]. ANNALES DE MEDECINE INTERNE, 1984, 135 (08): : 633 - 636
  • [10] NON-STEROIDAL ANTI-INFLAMMATORY DRUGS
    BISCARINI, L
    DELFAVERO, A
    [J]. MEDICINA-RIVISTA DELLA ENCICLOPEDIA MEDICA ITALIANA, 1989, 9 (03): : 249 - 264